G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications

An In vivo Drug Screening Model Using Glucose-6-Phosphate Dehydrogenase Deficient Mice to Predict the Hemolytic Toxicity of 8-Aminoquinolines

(2013) Peng Zhang et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

A model of glucose-6-phosphate dehydrogenase deficiency in the zebrafish

(2013) Xiaobai Patrinostro et al.   EXPERIMENTAL HEMATOLOGY

Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase

(2012) Mohamad Bassam Sonbol et al.   AMERICAN JOURNAL OF HEMATOLOGY

Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone

(2012) A. Pamba et al.   BLOOD

Glucose-6-phosphate dehydrogenase (G6PD) mutations database: Review of the “old” and update of the new mutations

(2012) Angelo Minucci et al.   BLOOD CELLS MOLECULES AND DISEASES

Rapid and simple identification of the commonest glucose-6-phosphate dehydrogenase (G6PD) Italian mutations: From DNA extraction to genotyping

(2012) Angelo Minucci et al.   CLINICA CHIMICA ACTA

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common

(2012) Nicholas J White et al.   MALARIA JOURNAL

Lethal Effect of a Single Dose of Rasburicase in a Preterm Newborn Infant

(2012) P. Zaramella et al.   PEDIATRICS

Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs

(2012) Olaf Müller et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map

(2012) Rosalind E. Howes et al.   PLOS MEDICINE

Considerations when prescribing trimethoprim-sulfamethoxazole

(2011) J. M.- W. Ho et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia

(2011) T. Bauters et al.   International Journal of Clinical Pharmacy

A ghostly presence-G6PD deficiency

(2010) Barbara J. Bain   AMERICAN JOURNAL OF HEMATOLOGY

Ciprofloxacin-induced acute haemolytic anaemia in a patient with glucose-6-phosphate dehydrogenase Mediterranean deficiency: a case report

(2010) Stefano Sansone et al.   ANNALS OF HEMATOLOGY

Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus

(2010) Mitchell S. Cairo et al.   BRITISH JOURNAL OF HAEMATOLOGY

Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

(2010) Ilan Youngster et al.   DRUG SAFETY

The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics

(2010) Lucio Luzzatto   LANCET

Identification of the miR-106b 25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation

(2010) L. Poliseno et al.   Science Signaling

Chlorproguanil–Dapsone–Artesunate versus Chlorproguanil–Dapsone: A Randomized, Double-Blind, Phase III Trial in African Children, Adolescents, and Adults with Uncomplicated Plasmodium falciparum Malaria

(2009) Alfred B. Tiono et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria

(2009) Zul Premji et al.   PLoS One

Primaquine revisited six decades after its discovery

(2008) Nuno Vale et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Glucose-6-phosphate dehydrogenase deficiency

(2008) MD Cappellini et al.   LANCET

L’ofloxacine est contre-indiquée en cas de déficit en glucose 6 phosphate déshydrogénase (G6PD) : une évidence médicale basée sur les preuves ?

(2008) T. Carmoi et al.   REVUE DE MEDECINE INTERNE